Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse

Nature Medicine

Volumn 24, Issue 4, 2018, Pages 474-483

  Good, Zinaida ^a,b   Sarno, Jolanda ^b,c   Jager, Astraea ^a,b   Samusik, Nikolay ^a,b   Aghaeepour, Nima ^a,b   Simonds, Erin F ^a,b,d   White, Leah ^b   Lacayo, Norman J ^b   Fantl, Wendy J ^b   Fazio, Grazia ^c   Gaipa, Giuseppe ^c   Biondi, Andrea ^c   Tibshirani, Robert ^b   Bendall, Sean C ^a   Nolan, Garry P ^a,b   Davis, Kara L ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; TARGET OF RAPAMYCIN KINASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER CLASSIFICATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LEUKEMIA CELL; LEUKEMIA RELAPSE; MACHINE LEARNING; MASS CYTOMETRY; MTOR SIGNALING; PHENOTYPE; PRE B LYMPHOCYTE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE CELL ANALYSIS; ADULT; B LYMPHOCYTE; CLASSIFICATION; FEMALE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE; RISK ASSESSMENT; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; YOUNG ADULT;

ADULT; B-LYMPHOCYTES; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECURRENCE; RISK ASSESSMENT; SIGNAL TRANSDUCTION; SINGLE-CELL ANALYSIS; SURVIVAL ANALYSIS; TOR SERINE-THREONINE KINASES; YOUNG ADULT;

EID: 85045265140     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.4505     Document Type: Article

References (50)

1. Anderson, K. et al. Genetic variegation of clonal architecture and propagating cells in leukemia. Nature 469, 356-361 (2011).
2. Walter, M.J. et al. Clonal architecture of secondary acute myeloid leukemia. N. Engl. J. Med. 366, 1090-1098 (2012).
3. Welch, J.S. et al. The origin and evolution of mutations in acute myeloid leukemia. Cell 150, 264-278 (2012).
4. Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883-892 (2012).
5. Klco, J.M. et al. Functional heterogeneity of genetically defined subclones in acute myeloid leukemia. Cancer Cell 25, 379-392 (2014).
6. Duque-Afonso, J. & Cleary, M.L. The AML salad bowl. Cancer Cell 25, 265-267 (2014).
7. Bhojwani, D. & Pui, C.H. Relapsed childhood acute lymphoblastic leukemia. Lancet Oncol. 14, e205-e217 (2013).
8. Greaves, M.F. Differentiation-linked leukemogenesis in lymphocytes. Science 234, 697-704 (1986).
9. Bhojwani, D. et al. Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study. Blood 108, 711-717 (2006).
10. Mullighan, C.G. et al. Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science 322, 1377-1380 (2008).
11. Hogan, L.E. et al. Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies. Blood 118, 5218-5226 (2011).
12. Mullighan, C.G. et al. BCR-ABL1 lymphoblastic leukemia is characterized by the deletion of Ikaros. Nature 453, 110-114 (2008).
13. LeBien, T.W. & Tedder, T.F. B lymphocytes: how they develop and function. Blood 112, 1570-1580 (2008).
14. Bendall, S.C. et al. Single-cell trajectory detection uncovers progression and regulatory coordination in human B cell development. Cell 157, 714-725 (2014).
15. Teachey, D.T. & Hunger, S.P. Predicting relapse risk in childhood acute lymphoblastic leukemia. Br. J. Haematol. 162, 606-620 (2013).
16. Spitzer, M.H. et al. An interactive reference framework for modeling a dynamic immune system. Science 349, 1259425 (2015).
17. Samusik, N., Good, Z., Spitzer, M.H., Davis, K.L. & Nolan, G.P. Automated mapping of phenotype space with single-cell data. Nat. Methods 13, 493-496 (2016).
18. Zunder, E.R., Lujan, E., Goltsev, Y., Wernig, M. & Nolan, G.P. A continuous molecular roadmap to iPSC reprogramming through progression analysis of single-cell mass cytometry. Cell. Stem Cell 16, 323-337 (2015).
19. Bicocca, V.T. et al. Cross-talk between ROR1 and the pre-B cell receptor promotes survival of t(1;19) acute lymphoblastic leukemia. Cancer Cell 22, 656-667 (2012).
20. Crist, W. et al. Prognostic importance of the pre-B cell immunophenotype and other presenting features in B lineage childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood 74, 1252-1259 (1989).
21. Mullighan, C.G. et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukemia. Nature 446, 758-764 (2007).
22. Friedman, J., Hastie, T. & Tibshirani, R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33, 1-22 (2010).
23. Tibshirani, R. The lasso method for variable selection in the Cox model. Stat. Med. 16, 385-395 (1997).
24. Tibshirani, R.J. & Efron, B. Pre-validation and inference in microarrays. Stat. Appl. Genet. Mol. Biol. 1, Article1 (2002).
25. Höfling, H. & Tibshirani, R. A study of pre-validation. Ann. Appl. Stat. 2, 643-664 (2008).
26. Uno, H., Cai, T., Tian, L. & Wei, L.J. Evaluating prediction rules for t-year survivors with censored regression models. J. Am. Stat. Assoc. 102, 527-537 (2007).
27. Uno, H., Cai, T., Pencina, M.J., D'Agostino, R.B. & Wei, L.J. On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Statist. Med. 121, 1105-1117 (2011).
28. Smith, M. et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J. Clin. Oncol. 14, 18-24 (1996).
29. Basso, G. et al. Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow. J. Clin. Oncol. 27, 5168-5174 (2009).
30. Borowitz, M.J. et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study. Blood 111, 5477-5485 (2008).
31. Pencina, M.J., D'Agostino, R.B. Sr. & Steyerberg, E.W. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat. Med. 30, 11-21 (2011).
32. Uno, H., Tian, L., Cai, T., Kohane, I.S. & Wei, L.J. A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data. Stat. Med. 32, 2430-2442 (2013).
33. Krishnaswamy, S. et al. Conditional density-based analysis of T cell signaling in single-cell data. Science 346, 1250689 (2014).
34. Clark, M.R., Mandal, M., Ochiai, K. & Singh, H. Orchestrating B cell lymphopoiesis through interplay of IL7 receptor and preB cell receptor signaling. Nat. Rev. Immunol. 14, 69-80 (2014).
35. O'Reilly, L.A. et al. MEK/ERK-mediated phosphorylation of Bim is required to ensure survival of T and B lymphocytes during mitogenic stimulation. J. Immunol. 183, 261-269 (2009).
36. Alizadeh, A.A. et al. Distinct types of diffuse large B cell lymphoma identified by gene expression profiling. Nature 403, 503-511 (2000).
37. Trageser, D. et al. Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function. J. Exp. Med. 206, 1739-1753 (2009).
38. Feldhahn, N. et al. Mimicry of a constitutively active pre-B cell receptor in acute lymphoblastic leukemia cells. J. Exp. Med. 201, 1837-1852 (2005).
39. Shojaee, S. et al. PTEN opposes negative selection and enables oncogenic transformation of pre-B cells. Nat. Med. 22, 379-387 (2016).
40. Kotecha, N. et al. Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates. Cancer Cell 14, 335-343 (2008).
41. Gibbs, K.D. Jr. et al. Decoupling of tumor-initiating activity from stable immunophenotype in HoxA9-Meis1-driven AML. Cell. Stem Cell 10, 210-217 (2012).
42. Irish, J.M. et al. B cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression. Proc. Natl. Acad. Sci. USA 107, 12747-12754 (2010).
43. Irish, J.M. et al. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 118, 217-228 (2004).
44. Levine, J.H. et al. Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis. Cell 162, 184-197 (2015).
45. Conter, V. et al. Molecular response to treatment redefines all prognostic factors in children and adolescents with B cell precursor acute lymphoblastic leukemia: results in 3,184 patients of the AIEOP-BFM ALL 2000 study. Blood 115, 3206-3214 (2010).
46. WHO Expert Committee. Acute lymphoblastic leukemia in children: a brief review of the internationally available protocols. (Second Meeting of the Subcommittee of the Expert Committee on the Selection and Use of Essential Medicines) 1-11 (World Health Organization, Geneva, 2008).
47. Bendall, S.C. et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 332, 687-696 (2011).
48. Fienberg, H.G., Simonds, E.F., Fantl, W.J., Nolan, G.P. & Bodenmiller, B. A platinum-based covalent viability reagent for single-cell mass cytometry. Cytometry A 81, 467-475 (2012).
49. Zunder, E.R. et al. Palladium-based mass tag cell barcoding with a doublet-filtering scheme and single-cell deconvolution algorithm. Nat. Protoc. 10, 316-333 (2015).
50. Finck, R. et al. Normalization of mass cytometry data with bead standards. Cytometry A 83, 483-494 (2013).